StonvexLoading…
StonvexStonvexStonvexCore line items from HSIC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.18B | $12.67B | $12.34B | $12.65B |
Operating Income | $653.00M | $621.00M | $615.00M | $747.00M |
Net Income | $398.00M | $390.00M | $416.00M | $538.00M |
EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 |
Total Assets | $11.21B | $10.22B | $10.57B | $8.61B |
Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B |
Cash & Equivalents | $156.00M | $122.00M | $171.00M | $117.00M |
Free Cash Flow OCF − CapEx | $573.00M | $700.00M | $353.00M | $506.00M |
Shares Outstanding | 115.77M | 124.16M | 129.25M | 131.79M |